Search research articles
Contact Us
Filters
Showing results (11-20 of 182) with videos related to
Page
of 19
Sort By:
Geriatrics
|
July 1, 1988
Atypical presentation of endocrine disorders in the elderly
S R Gambert, J E Escher
European Journal of Pharmacology
|
February 24, 1987
Effects of substance P analogues in the rat tail-flick test
R Couture, E Escher, D Regoli
Regulatory Peptides
|
April 16, 1998
The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors
G Servant, E Escher, G Guillemette
Regulatory Peptides
|
August 13, 1993
The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2
M C Paré, S Maltais, E Escher
Brain Research
|
June 21, 1988
Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex
T V Dam, E Escher, R Quirion
Frontiers in Toxicology
|
November 8, 2024
Assessment of pulmonary fibrosis using weighted gene co-expression network analysis
Christina Drake, Walter Zobl, Sylvia E Escher
Brain Research
|
January 1, 1990
Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide
T V Dam, E Escher, R Quirion
Biochemical and Biophysical Research Communications
|
November 30, 1987
Apparent molecular weight of substance P/neurokinin-1 receptors determined using a photoaffinity labelled probe, [(3'-125I) D-Tyro, (4'-N3)Phe8, Nle11]-substance P
T V Dam, E Escher, R Quirion
Allergy
|
October 28, 2004
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases
J Elsner, S E Escher, U Forssmann
Canadian Journal of Physiology and Pharmacology
|
December 1, 1978
Photoaffinity labeling of the angiotensin II receptor; pharmacology of the labeling peptides in the dark
E Escher, T M Nguyen, D Regoli
Page
of 19
Search research articles
Search
Showing results (11-20 of 182) with videos related to
Sort By:
Page
of 19
Geriatrics
|
July 1, 1988
Atypical presentation of endocrine disorders in the elderly
S R Gambert, J E Escher
European Journal of Pharmacology
|
February 24, 1987
Effects of substance P analogues in the rat tail-flick test
R Couture, E Escher, D Regoli
Regulatory Peptides
|
April 16, 1998
The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors
G Servant, E Escher, G Guillemette
Regulatory Peptides
|
August 13, 1993
The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2
M C Paré, S Maltais, E Escher
Brain Research
|
June 21, 1988
Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex
T V Dam, E Escher, R Quirion
Frontiers in Toxicology
|
November 8, 2024
Assessment of pulmonary fibrosis using weighted gene co-expression network analysis
Christina Drake, Walter Zobl, Sylvia E Escher
Brain Research
|
January 1, 1990
Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide
T V Dam, E Escher, R Quirion
Biochemical and Biophysical Research Communications
|
November 30, 1987
Apparent molecular weight of substance P/neurokinin-1 receptors determined using a photoaffinity labelled probe, [(3'-125I) D-Tyro, (4'-N3)Phe8, Nle11]-substance P
T V Dam, E Escher, R Quirion
Allergy
|
October 28, 2004
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases
J Elsner, S E Escher, U Forssmann
Canadian Journal of Physiology and Pharmacology
|
December 1, 1978
Photoaffinity labeling of the angiotensin II receptor; pharmacology of the labeling peptides in the dark
E Escher, T M Nguyen, D Regoli
Page
of 19